VCT 26: AMER Stage 2Group Stage ⋅ W4
LEV2:0MIBR

Francisco Aravena
LEVIATÁN| Agent | Use | Rnd | Rating | ACS | K:D | KAST | ADR | KPR | APR | FK:FD |
|---|---|---|---|---|---|---|---|---|---|---|
| 164 · 33% | 3447 | 1.16 | 216 | 1.23 | 77% | 140.6 | 0.75 | 0.32 | 1.23 | |
| 81 · 17% | 1698 | 1.17 | 253 | 1.27 | 73% | 159.2 | 0.86 | 0.23 | 1.49 | |
| 77 · 16% | 1648 | 1.08 | 189 | 1.11 | 77% | 121.7 | 0.68 | 0.43 | 1.08 | |
| 32 · 7% | 668 | 1.12 | 222 | 1.11 | 74% | 144.1 | 0.75 | 0.43 | 1.13 | |
| 28 · 6% | 587 | 1.09 | 189 | 1.17 | 74% | 118.3 | 0.68 | 0.34 | 1.76 | |
| 24 · 5% | 501 | 1.14 | 200 | 1.23 | 78% | 130.0 | 0.73 | 0.36 | 1.10 | |
| 21 · 4% | 406 | 1.16 | 208 | 1.25 | 78% | 128.2 | 0.75 | 0.43 |
| 1.34 |
| 16 · 3% | 339 | 1.00 | 217 | 1.08 | 68% | 137.2 | 0.76 | 0.20 | 0.88 |
| 15 · 3% | 303 | 1.26 | 257 | 1.51 | 78% | 153.9 | 0.94 | 0.28 | 1.40 |
| 8 · 2% | 176 | 1.17 | 215 | 1.23 | 71% | 139.0 | 0.75 | 0.37 | 0.91 |
| 8 · 2% | 148 | 0.87 | 160 | 0.89 | 72% | 108.7 | 0.57 | 0.26 | 1.20 |
| 6 · 1% | 138 | 0.75 | 141 | 0.69 | 71% | 93.2 | 0.49 | 0.30 | 2.33 |
| 5 · 1% | 96 | 0.90 | 188 | 0.86 | 68% | 123.2 | 0.64 | 0.16 | 0.83 |
| 2 · 0% | 39 | 1.25 | 218 | 1.50 | 87% | 138.4 | 0.77 | 0.23 | 6.00 |
| 1 · 0% | 26 | 0.91 | 178 | 1.00 | 65% | 112.1 | 0.65 | 0.23 | 0.50 |
| 1 · 0% | 17 | – | 239 | 1.00 | – | 144.1 | 0.82 | 0.18 | 1.00 |
| 1 · 0% | 17 | 1.09 | 203 | 1.30 | 76% | 133.7 | 0.76 | 0.06 | 1.33 |
LEV2:0MIBR
LEV1:2NRG
LEV2:0ENVY
LEV2:0EG
LEV2:1FUR